• What we do

    What we do +

    Bringing cloud based infrastructure, scientific expertise and full service to support the optimal design and efficient management of clinical trials, where imaging provides critical evidence of the novel compound safety and efficacy.

    Imaging Expertise

    Imaging Expertise +

    Expert opinions and video lectures on the latest technologies for visualisation, analysis, and reporting of DCE-MRI and MRI images acquired in clinical or pre-clinical studies.

    Management

    Management +

    Innovation driven, agile and dedicated team, working in partnership with leading academics and clinical specialists and delivering operational, strategic and partnering support to ensure the success of your clinical study.

    Cloud-Based System

    Cloud-Based System +

    Dynamika is used by bio- pharmaceutical companies and academic investigators to improve image logistics, automate image quality assurance, and standardize advanced imaging data analysis.

  • Trial Services

    Trial Services +

    We deliver accurate and comprehensive image analytics and provide full support of early phase trials and R&D studies crucial to make go / no-go decision on further development of the compound.

    Therapeutic Areas

    Therapeutic Areas +

    We deliver the most comprehensive set of imaging markers and ensure that Sponsors and Investigators are fully informed of the treatment profile when making a decision on the success of the compound.

    Clinical Trial Team

    Clinical Trial Team +

    Dedicated team of clinical and radiology experts, software engineers and algorithm developers will be engaged to deliver bespoke end-to-end support for your imaging study.

    Imaging Expertise

    Imaging Expertise +

    Expert opinions and video lectures on the latest technologies for visualisation, analysis, and reporting of DCE-MRI and MRI images acquired in clinical or pre-clinical studies.

  • Your Study Initiation

    Your Study Initiation +

    Delivering your study on budget and on time with the cloud based infrastructure, patented scoring methodologies for advanced imaging and a network of therapeutic and imaging experts.

    Case Studies

    Case Studies +

    Case studies and clinical routine examples of using advanced imaging and quantitative image markers for highly efficient interpretation and management of imaging data

    Dynamika for Research

    Dynamika for Research +

    Dynamika is the best link between cutting academic research and clinical trial word. We ensure that you benefit from the latest science delivered within standardized regulated environment

    Cloud-Based System

    Cloud-Based System +

    Dynamika is used by bio- pharmaceutical companies and academic investigators to improve image logistics, automate image quality assurance, and standardize advanced imaging data analysis.

  • Connect



    DYNAMIKA USERS:
    E: dynamika@imageanalysis.org.uk
    T: + 44 7413 022053

    PROJECT SUPPORT:
    E: support@imageanalysisgroup.com

    UK: +44 7812 001187

    USA: + 1 6177 523561



    Discuss your Study (Europe)

    T: + 44 7413 022053
    E: contact@imageanalysisgroup.com

    Discuss your Study (United States)

    T: + 1 6177 523561
    E: contact@imageanalysisgroup.com

Company News

Quantification and distribution of Gd retention – new imaging study results

In response to concerns by radiology community of Gd retention, Guerbet Group and Image Analysis complete a pre-clinical study, which aimed to evaluate the absorption rate of gadolinium (Gd) -based contrast agents and the Gd retention using an animal model.  The brain tissue retention of Gd was studied in healthy rats that received regular linear Gd contrast agent (GBCAs) injections compared with a [...]

Integrated pharmacokinetic analysis tools to support oncology clinical research studies – Dynamika Enterprise 4.2.4 released

Dynamika Enterprise v. 4.2.4, the industry leading fully integrated cloud based software platform for clinical trial data management has been released by Image Analysis Group on Sept., 09 2016. Dynamika now integrates the full pharmacokinetic analysis suite and advanced computer-aided analysis methodologies to support the precise quantification of imaging data from oncology and  immuno-oncology clinical programmes. [...]

Disease management and decision making in Juvenile Idiopathic Arthritis – results of the clinical research study published

A new study assesses the diagnostic and predictive value of quantitative MRI biomarkers in Juvenile Idiopathic Arthritis. The study compares MRI based scores (such as DEMRIQ, Dynamika) to the clinical outcome measures in 8 patients with polyarticular JIA, with standardized DMARD treatment. The study concludes that MRI based scores (obtained with Dynamika) are useful for [...]

View all news

Blog

Image Analysis collaborates with major German Hospital Charité on the application of MRI in Musculoskeletal Diseases

Image Analysis, Charité – Universitätsmedizin Berlin and Charité Research Organisation to collaborate on furthering Research & Development of contrast enhanced MRI in musculoskeletal conditions. The collaboration will be focusing on projects such as: DCE-MRI analysis in Rheumatoid arthritis DCE-MRI and contrast enhanced Computer tomography (dynCT) comparison DCE-MRI in ankylosing spondylitis The main goals of this [...]

Danger of ‘Gadolinium Phobia’

By Philip Ward, AuntMinnie.com staff writer March 4, 2016 Post European Congress of Radiology (ECR) and publication of several articles in European newspapers, AuntMinnie, the leading radiology news website reports that ‘there’s a serious risk of a phobia developing over the use of gadolinium-based MRI contrast agents’. At ECR, Dr. Alexander Radbruch, a radiologist at Heidelberg University [...]

Synovitis in knee osteoarthritis: a precursor of disease?

Synovitis in knee osteoarthritis: a precursor of disease? - another evidence paper confirming the importance of measuring early inflammatory changes occurring prior to degenerative damage in patients with osteoarthritis (OA) is now available on:http://ard.bmj.com/content/early/2014/12/08/annrheumdis-2014-205894.abstract This late 2014 paper has been followed on by a number of research papers confirming the need for earlier biomarkers in OA [...]

View more posts

Latest Tweets

RT @vRad: Report says CAD will dominate #imaging market for next 5 years due to #mammography & #MRI applications http://t.co/Divka2CZWx

RT @BioMedCentral: RT @stefaniealaimo: #MRI detects early effects of #chemotherapy on children’s hearts from @BioMedCentral blog http://t.c…

RT @OlgaKubassova: #Mammography has not reduced deaths from #breast cancer. Real need for effective #imaging for early detection - #MRI htt…

RT @OlgaKubassova: Early Treatment Start Key to RA Remission http://t.co/3AhJWLvqOB

Market growth & overview of #imageanalysis #software market driven by demand for diagnostic procedures & #technology http://t.co/wHoi0He0cL

@sarahhowardview @downingstreet brilliantly :) great event for #smallbusiness and #innovation driven enterprisers http://t.co/wJWvy5bmOe

RT @jemilad: Great talk by @OlgaKubassova on how @ImageAnalysisUK delivers objectivity, efficiency and precision in medical image analysis …